Concepts (203)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Uveitis, Anterior | 3 | 2006 | 15 | 0.550 |
Why?
|
| Phacoemulsification | 7 | 2009 | 69 | 0.530 |
Why?
|
| Keratomileusis, Laser In Situ | 8 | 2007 | 35 | 0.530 |
Why?
|
| Keratitis | 6 | 2006 | 20 | 0.510 |
Why?
|
| Corneal Ulcer | 3 | 2014 | 10 | 0.440 |
Why?
|
| Surgical Flaps | 6 | 2005 | 120 | 0.420 |
Why?
|
| Cornea | 5 | 2006 | 76 | 0.390 |
Why?
|
| Refractive Surgical Procedures | 5 | 2007 | 16 | 0.390 |
Why?
|
| Corneal Stroma | 6 | 2015 | 20 | 0.380 |
Why?
|
| Postoperative Complications | 9 | 2017 | 1615 | 0.380 |
Why?
|
| Fuchs' Endothelial Dystrophy | 2 | 2012 | 6 | 0.370 |
Why?
|
| Ketorolac Tromethamine | 4 | 2006 | 16 | 0.340 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 4 | 2006 | 240 | 0.330 |
Why?
|
| Myopia | 3 | 2005 | 27 | 0.320 |
Why?
|
| Diagnostic Techniques, Ophthalmological | 3 | 2004 | 19 | 0.310 |
Why?
|
| Ophthalmology | 2 | 2005 | 39 | 0.290 |
Why?
|
| Keratitis, Herpetic | 1 | 2006 | 2 | 0.280 |
Why?
|
| Chickenpox | 1 | 2006 | 14 | 0.280 |
Why?
|
| Keratoplasty, Penetrating | 2 | 2005 | 6 | 0.280 |
Why?
|
| Pemphigoid, Benign Mucous Membrane | 1 | 2006 | 3 | 0.280 |
Why?
|
| Ophthalmoplegia | 1 | 2006 | 20 | 0.280 |
Why?
|
| Conjunctivitis | 1 | 2006 | 6 | 0.280 |
Why?
|
| Paraneoplastic Syndromes | 1 | 2006 | 15 | 0.270 |
Why?
|
| Immunoglobulin Heavy Chains | 1 | 2006 | 72 | 0.270 |
Why?
|
| Carcinoma, Bronchogenic | 1 | 2006 | 18 | 0.270 |
Why?
|
| Genes, Immunoglobulin | 1 | 2006 | 56 | 0.270 |
Why?
|
| Refractive Errors | 3 | 2017 | 24 | 0.270 |
Why?
|
| Herpes Zoster Ophthalmicus | 1 | 2005 | 4 | 0.270 |
Why?
|
| Temporal Arteries | 1 | 2005 | 7 | 0.270 |
Why?
|
| Giant Cell Arteritis | 1 | 2005 | 10 | 0.270 |
Why?
|
| Eye Infections, Fungal | 1 | 2005 | 7 | 0.260 |
Why?
|
| Dry Eye Syndromes | 1 | 2005 | 12 | 0.260 |
Why?
|
| Disease Transmission, Infectious | 1 | 2005 | 25 | 0.260 |
Why?
|
| Cryptococcosis | 1 | 2005 | 28 | 0.260 |
Why?
|
| Sensation | 1 | 2005 | 49 | 0.260 |
Why?
|
| Photorefractive Keratectomy | 3 | 2015 | 12 | 0.250 |
Why?
|
| Lens Implantation, Intraocular | 7 | 2012 | 152 | 0.240 |
Why?
|
| Eye Infections, Bacterial | 3 | 2014 | 15 | 0.230 |
Why?
|
| Tissue Donors | 1 | 2005 | 195 | 0.230 |
Why?
|
| Polychondritis, Relapsing | 1 | 2003 | 3 | 0.230 |
Why?
|
| Practice Patterns, Physicians' | 2 | 2005 | 504 | 0.220 |
Why?
|
| Conjunctiva | 2 | 2017 | 16 | 0.210 |
Why?
|
| Androstadienes | 1 | 2002 | 41 | 0.200 |
Why?
|
| Descemet Stripping Endothelial Keratoplasty | 2 | 2012 | 2 | 0.200 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2006 | 629 | 0.190 |
Why?
|
| Prednisolone | 3 | 2006 | 23 | 0.180 |
Why?
|
| Photosensitizing Agents | 2 | 2015 | 32 | 0.180 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2002 | 234 | 0.170 |
Why?
|
| Staphylococcal Infections | 2 | 2014 | 156 | 0.170 |
Why?
|
| Cataract Extraction | 4 | 2012 | 127 | 0.170 |
Why?
|
| Middle Aged | 16 | 2012 | 21147 | 0.160 |
Why?
|
| Glucocorticoids | 3 | 2006 | 222 | 0.160 |
Why?
|
| Corneal Diseases | 2 | 2012 | 12 | 0.160 |
Why?
|
| Humans | 30 | 2017 | 68618 | 0.160 |
Why?
|
| Intraoperative Complications | 3 | 2010 | 129 | 0.150 |
Why?
|
| Ophthalmic Solutions | 4 | 2006 | 39 | 0.150 |
Why?
|
| Lung Neoplasms | 1 | 2006 | 1173 | 0.150 |
Why?
|
| Pterygium | 1 | 2017 | 3 | 0.150 |
Why?
|
| Ultrasonic Therapy | 2 | 2008 | 19 | 0.140 |
Why?
|
| Disease Models, Animal | 6 | 2006 | 2550 | 0.130 |
Why?
|
| Endothelium, Corneal | 2 | 2006 | 20 | 0.130 |
Why?
|
| Aged | 12 | 2010 | 14862 | 0.130 |
Why?
|
| Male | 18 | 2012 | 37321 | 0.130 |
Why?
|
| Keratoconus | 1 | 2015 | 4 | 0.130 |
Why?
|
| Visual Acuity | 7 | 2012 | 236 | 0.120 |
Why?
|
| Female | 19 | 2012 | 38074 | 0.120 |
Why?
|
| Prosthesis Implantation | 1 | 2015 | 83 | 0.120 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2014 | 92 | 0.110 |
Why?
|
| Anterior Chamber | 2 | 2010 | 20 | 0.110 |
Why?
|
| Epithelium, Corneal | 1 | 2012 | 3 | 0.110 |
Why?
|
| Diagnosis, Differential | 2 | 2006 | 1140 | 0.110 |
Why?
|
| Intraocular Pressure | 4 | 2008 | 143 | 0.100 |
Why?
|
| Refraction, Ocular | 3 | 2010 | 61 | 0.090 |
Why?
|
| Transforming Growth Factor beta2 | 1 | 2010 | 19 | 0.090 |
Why?
|
| Glaucoma, Open-Angle | 1 | 2010 | 19 | 0.090 |
Why?
|
| Pseudophakia | 1 | 2010 | 27 | 0.090 |
Why?
|
| Aqueous Humor | 1 | 2010 | 51 | 0.090 |
Why?
|
| Aged, 80 and over | 6 | 2010 | 4848 | 0.090 |
Why?
|
| Adult | 10 | 2010 | 21403 | 0.090 |
Why?
|
| Lenses, Intraocular | 1 | 2010 | 96 | 0.090 |
Why?
|
| Cataract | 2 | 2010 | 134 | 0.090 |
Why?
|
| Iris Diseases | 1 | 2009 | 8 | 0.080 |
Why?
|
| Iris | 1 | 2009 | 27 | 0.080 |
Why?
|
| Adrenergic alpha-Antagonists | 1 | 2009 | 32 | 0.080 |
Why?
|
| Adrenergic alpha-1 Receptor Antagonists | 1 | 2009 | 20 | 0.080 |
Why?
|
| Rabbits | 6 | 2006 | 509 | 0.080 |
Why?
|
| Postoperative Period | 2 | 2008 | 238 | 0.080 |
Why?
|
| Surveys and Questionnaires | 3 | 2005 | 2800 | 0.080 |
Why?
|
| Staining and Labeling | 2 | 2005 | 144 | 0.080 |
Why?
|
| Sulfonamides | 1 | 2009 | 141 | 0.080 |
Why?
|
| Pupil | 2 | 2007 | 51 | 0.070 |
Why?
|
| Staphylococcus aureus | 2 | 2006 | 175 | 0.070 |
Why?
|
| Nedocromil | 2 | 2004 | 7 | 0.070 |
Why?
|
| Child | 3 | 2007 | 6405 | 0.070 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 2006 | 44 | 0.070 |
Why?
|
| Anti-Bacterial Agents | 3 | 2014 | 1026 | 0.070 |
Why?
|
| Gene Frequency | 1 | 2006 | 207 | 0.070 |
Why?
|
| Endophthalmitis | 1 | 2006 | 15 | 0.070 |
Why?
|
| Ophthalmic Nerve | 1 | 2005 | 4 | 0.070 |
Why?
|
| Fatal Outcome | 1 | 2006 | 164 | 0.070 |
Why?
|
| Tears | 1 | 2005 | 9 | 0.070 |
Why?
|
| Acyclovir | 1 | 2005 | 38 | 0.070 |
Why?
|
| Valine | 1 | 2005 | 43 | 0.070 |
Why?
|
| Fluoroquinolones | 1 | 2006 | 49 | 0.070 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2006 | 62 | 0.070 |
Why?
|
| Contrast Sensitivity | 1 | 2005 | 28 | 0.060 |
Why?
|
| Double-Blind Method | 3 | 2006 | 1738 | 0.060 |
Why?
|
| Polymerase Chain Reaction | 1 | 2006 | 492 | 0.060 |
Why?
|
| Societies, Medical | 2 | 2005 | 403 | 0.060 |
Why?
|
| Single-Blind Method | 1 | 2005 | 249 | 0.060 |
Why?
|
| Geography | 1 | 2004 | 80 | 0.060 |
Why?
|
| Genotype | 1 | 2006 | 786 | 0.060 |
Why?
|
| Cyclopentolate | 1 | 2003 | 3 | 0.060 |
Why?
|
| Mydriatics | 1 | 2003 | 4 | 0.060 |
Why?
|
| Prospective Studies | 4 | 2006 | 3705 | 0.060 |
Why?
|
| Immunoglobulin G | 1 | 2006 | 481 | 0.060 |
Why?
|
| Follow-Up Studies | 2 | 2010 | 3259 | 0.060 |
Why?
|
| Reoperation | 1 | 2005 | 467 | 0.060 |
Why?
|
| Drug Residues | 1 | 2003 | 6 | 0.060 |
Why?
|
| Biopsy | 1 | 2005 | 540 | 0.060 |
Why?
|
| Corneal Neovascularization | 1 | 2003 | 6 | 0.060 |
Why?
|
| Detergents | 1 | 2003 | 34 | 0.060 |
Why?
|
| Porphyrins | 1 | 2003 | 15 | 0.060 |
Why?
|
| Antiviral Agents | 1 | 2005 | 211 | 0.060 |
Why?
|
| Mycobacterium chelonae | 1 | 2003 | 9 | 0.060 |
Why?
|
| Eye Diseases | 1 | 2003 | 38 | 0.060 |
Why?
|
| Biological Factors | 1 | 2003 | 11 | 0.050 |
Why?
|
| Time Factors | 3 | 2008 | 4655 | 0.050 |
Why?
|
| Ear Diseases | 1 | 2003 | 37 | 0.050 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2006 | 786 | 0.050 |
Why?
|
| Photochemotherapy | 1 | 2003 | 59 | 0.050 |
Why?
|
| Treatment Outcome | 5 | 2010 | 7029 | 0.050 |
Why?
|
| Mycobacterium Infections, Nontuberculous | 1 | 2003 | 37 | 0.050 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2007 | 529 | 0.050 |
Why?
|
| Loteprednol Etabonate | 1 | 2002 | 4 | 0.050 |
Why?
|
| Foreign-Body Reaction | 1 | 2002 | 24 | 0.050 |
Why?
|
| Safety | 1 | 2002 | 145 | 0.050 |
Why?
|
| Animals | 7 | 2006 | 20881 | 0.050 |
Why?
|
| Epithelial Cells | 1 | 2002 | 431 | 0.040 |
Why?
|
| Lasers, Excimer | 2 | 2012 | 10 | 0.040 |
Why?
|
| Pseudomonas aeruginosa | 3 | 2004 | 133 | 0.040 |
Why?
|
| Adolescent | 2 | 2007 | 8912 | 0.040 |
Why?
|
| Lipopolysaccharides | 3 | 2004 | 455 | 0.040 |
Why?
|
| United States | 2 | 2005 | 7367 | 0.030 |
Why?
|
| Dilatation, Pathologic | 1 | 2015 | 58 | 0.030 |
Why?
|
| Cross-Linking Reagents | 1 | 2015 | 80 | 0.030 |
Why?
|
| Mice | 1 | 2006 | 8474 | 0.030 |
Why?
|
| Recurrence | 1 | 2017 | 948 | 0.030 |
Why?
|
| Prostheses and Implants | 1 | 2015 | 159 | 0.030 |
Why?
|
| Retrospective Studies | 4 | 2010 | 7277 | 0.030 |
Why?
|
| Preoperative Care | 2 | 2007 | 275 | 0.030 |
Why?
|
| Corneal Topography | 1 | 2012 | 2 | 0.030 |
Why?
|
| Astigmatism | 1 | 2012 | 17 | 0.030 |
Why?
|
| Collagen | 1 | 2015 | 636 | 0.020 |
Why?
|
| Drug Therapy, Combination | 2 | 2003 | 649 | 0.020 |
Why?
|
| Corneal Endothelial Cell Loss | 1 | 2010 | 2 | 0.020 |
Why?
|
| Fibrosis | 1 | 2012 | 371 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 507 | 0.020 |
Why?
|
| Syndrome | 1 | 2009 | 255 | 0.020 |
Why?
|
| Risk Factors | 2 | 2009 | 5731 | 0.020 |
Why?
|
| Drug Evaluation | 1 | 2006 | 47 | 0.020 |
Why?
|
| Instillation, Drug | 1 | 2006 | 15 | 0.020 |
Why?
|
| Cell Count | 1 | 2006 | 248 | 0.020 |
Why?
|
| Administration, Topical | 1 | 2006 | 111 | 0.020 |
Why?
|
| Age Factors | 1 | 2010 | 1864 | 0.020 |
Why?
|
| Keratectomy, Subepithelial, Laser-Assisted | 1 | 2005 | 3 | 0.020 |
Why?
|
| Body Weights and Measures | 1 | 2004 | 11 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2006 | 453 | 0.010 |
Why?
|
| Cadaver | 1 | 2004 | 136 | 0.010 |
Why?
|
| Ciliary Body | 1 | 2003 | 52 | 0.010 |
Why?
|
| Anterior Eye Segment | 1 | 2003 | 13 | 0.010 |
Why?
|
| Clarithromycin | 1 | 2003 | 11 | 0.010 |
Why?
|
| Stainless Steel | 1 | 2003 | 31 | 0.010 |
Why?
|
| Amikacin | 1 | 2003 | 13 | 0.010 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2004 | 137 | 0.010 |
Why?
|
| Patient Satisfaction | 1 | 2006 | 378 | 0.010 |
Why?
|
| Bodily Secretions | 1 | 2003 | 3 | 0.010 |
Why?
|
| Ofloxacin | 1 | 2003 | 15 | 0.010 |
Why?
|
| Meibomian Glands | 1 | 2003 | 4 | 0.010 |
Why?
|
| Soaps | 1 | 2003 | 5 | 0.010 |
Why?
|
| Indicators and Reagents | 1 | 2003 | 63 | 0.010 |
Why?
|
| Exotoxins | 1 | 2003 | 4 | 0.010 |
Why?
|
| Solutions | 1 | 2003 | 115 | 0.010 |
Why?
|
| Ciprofloxacin | 1 | 2003 | 30 | 0.010 |
Why?
|
| Lasers | 1 | 2003 | 61 | 0.010 |
Why?
|
| Povidone-Iodine | 1 | 2003 | 16 | 0.010 |
Why?
|
| Tobramycin | 1 | 2003 | 38 | 0.010 |
Why?
|
| Bacteriological Techniques | 1 | 2003 | 49 | 0.010 |
Why?
|
| Laser Coagulation | 1 | 2002 | 8 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 2003 | 215 | 0.010 |
Why?
|
| Postoperative Care | 1 | 2004 | 163 | 0.010 |
Why?
|
| Hot Temperature | 1 | 2003 | 152 | 0.010 |
Why?
|
| Health Surveys | 1 | 2005 | 489 | 0.010 |
Why?
|
| Cryotherapy | 1 | 2002 | 36 | 0.010 |
Why?
|
| Titanium | 1 | 2003 | 118 | 0.010 |
Why?
|
| Water | 1 | 2003 | 230 | 0.010 |
Why?
|
| Models, Animal | 1 | 2003 | 252 | 0.010 |
Why?
|
| Bacteria | 1 | 2003 | 193 | 0.010 |
Why?
|
| Anti-Infective Agents | 1 | 2003 | 166 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2003 | 1040 | 0.010 |
Why?
|
| Inflammation | 1 | 2006 | 1030 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2007 | 3187 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2004 | 2077 | 0.010 |
Why?
|